CROI 2016 Program at a Glance

Keyword Index

Clinical prediction rule - 742 Clinical trial - 25, 26LB, 354, 436, 443, 494LB, 681, 700, 741LB, 816, 817, 873 Clonal expansion - 84, 85, 337, 339, 340, 361 Clonal HIV populations - 339, 361 Cluster RandomizedTrial - 50, 155, 219, 691, 985 CMV - 779, 780 Coagulation - 430, 714 Cobicistat - 430, 459 Cocaine - 693 Codon-pair bias - 227 Coffee - 549 Cognition - 422 Cognitive impairment - 144, 387, 421, 721 Cognitive performance - 148, 822 Cohort - 283, 860 Cohort study - 54, 227, 350, 421, 582, 584, 605, 698, 715, 943, 948 Coinfection - 526, 528, 583, 596, 755 Combination ART - 728 Community based - 70, 538LB, 983, 985 Community viral load - 1025, 1036 Community-Acquired Pneumonia - 769 Community-based HIV testing and counseling - 111, 740, 972, 975, 976, 983, 1059, 1061, 1062 Community-based intervention - 120, 436, 980 Comorbidity - 126, 612, 637, 690, 709, 713 Comorbidity - 801LB Compartmentalization - 143, 398, 400, 402, 406 Computer counseling intervention - 997 Computer simulation model - 336 Condoms - 863, 887, 1041 Continuum of care - 738, 994, 1002 Controllers - 261, 338 Copy NumberVariation - 201 Coreceptor switch - 306, 307 Coronary artery disease - 644, 648, 675 Coronary artery plaque - 648 Correlates of protection - 179 CorticalThickness - 385 Cost - 1050, 1059, 1061, 1062 Cost model - 115 Cost-effectiveness - 115, 536, 773, 945, 1052, 1056, 1058 Cotrimoxazole - 37, 773, 784, 801LB, 858 Couples - 49

Cross-sectional incidence testing - 511, 517, 520, 540, 976, 984 Cross-sectional study - 715, 1025 Crushing - 431 Cryptococcal antigenemia - 159, 759, 760, 761 Cryptococcal meningitis - 159, 759, 760, 762, 763

Directly-active-antiretroviral - 599 Disability - 721

Disclosure - 906, 974 Discontinuation - 765 Disparities - 721, 902, 990, 994, 1033 Disparity - 52 Diversity - 86, 179, 212, 331 DNA damage - 282, 629 DNA vaccine - 259LB Dolutegravir - 432, 438, 462, 508, 589, 660, 816, 947, 948, 953 Doravirine - 456, 470, 506 Dorsal root ganglia - 272 Drip feed - 431 Droplet digital PCR - 7 Drug - 363 • Combinations - 454, 462 • Discovery - 505 • Distribution - 412 • Interactions (DTG) – 10, 100, 430, 453, 455, 456, 459, 589, 1050 • Resistance - 16, 477, 498, 504, 543, 756, 847, 850 • Resistance mutations - 210, 406, 462, 465, • Resistance testing - 976 • Use - 149, 913, 915, 1041 Drug-resistant tuberculosis - 157, 754, 755 DualTherapy - 424LB DXA - 817 Dyslipidemia - 665, 854 –E– E/C/F/TAF - 496, 817 Early • AntiretroviralTherapy - 320, 473, 659, 843, 990 • ART start - 143, 291, 352, 942 • Diagnosis - 522, 675, 829 • Infant AntiretroviralTherapy - 658, 786 • Infant diagnosis - 782, 785, 786, 787, 788 • Infection - 84 • Mortality - 155, 747, 957 • Treatment - 1043 East Africa - 773, 979, 1062 Ebola - 72LB, 73LB, 74LB, 75LB, 76LB, 77LB, 910 Dolutegravir resistance - 480, 507 Dolutegravir resistance - 492LB 480, 483, 487, 488, 499, 505, 507 • Resistance surveillance - 492LB • HIV infection - 927 • HIV infection - 35LB

Cryptococcosis - 760, 762 Cryptococcus titers - 159 CSF biomarkers - 413

Cure - 342 CVD - 664 CX3CR1 - 732 CXCR4 - 306, 393

Cycling of Engagement - 1042 Cynomolgus monkey - 206, 319 CYP2B6 - 458 Cytokines – 259LB, 762

Cytomegalovirus (CMV) - 729, 730, 731, 732 CytotoxicT lymphocytes (CTL) – 13, 23, 94, 130, 259LB, 269, 300LB, 320, 374 –D– D-dimer - 645 DAA-based therapy - 589 Daclatasvir - 575, 577

Dapivirine - 872, 873, 1057, 1058 DapivirineVaginal Ring - 110LB Darunavir - 459, 574, 692, 775 Dasatinib - 468 Data linkage - 1053 DBS - 511 DC-SIGN - 547 ddPCR - 362 De novo immunogen design - 308

Decentralization - 789 Deep sequencing - 231 Defective provirus - 83

Democratic Republic of Congo - 213 Dendritic cells - 19, 128, 185, 186, 270, 288, 328 Depression - 414, 714, 919, 920, 1037 Developmental pharmacology - 440 Diabetes - 610 Diabetes mellitus - 647, 706 Diagnosis - 767 Diagnostic accuracy studies - 787 Didanosine - 811 Diet - 266, 657 Diffuse tensor imaging - 821 Direct transmission - 184, 220 Direct-acting antiviral (DAA) - 97, 455, 583, 585, 587, 600, 610

Keyword Index

CRF01_AE - 314 CRF02_AG - 222 Cross-reactivity - 313

Echocardiography - 649, 853 Economic evaluation - 834

CROI 2016 167